A Randomized Comparison of Twice-Daily Versus Once-Daily Asenapine for Schizophrenia

Next Previous
Trial Profile

A Randomized Comparison of Twice-Daily Versus Once-Daily Asenapine for Schizophrenia

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jul 2014

At a glance

  • Drugs Asenapine (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use

    • Most Recent Events

    • 23 May 2014 According to ClinicalTrials.gov record, status changed from not yet recruiting to completed.
    • 13 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top